Elevated [qlco]    
lysosomal protein transmembrane 4 beta [gngm]    
Independent [idcn]    
Prognostic Marker [qlco]    
PANCREATIC CARCINOMA [neop]    
objectives [inpr]    
investigate [ftcn]    
Relationship [qlco]    
lysosomal protein transmembrane 4 beta [gngm]    
LAPTM4B [gngm]    
PANCREATIC CARCINOMA [neop]    
Methods [inpr]    
LAPTM4B [gngm]    
Semi-quantitative [qnco]    
Immunohistochemistry [diap]    
PANCREATIC CARCINOMA [neop]    
specimens [sbst]    
Relationship [qlco]    
LAPTM4B [gngm]    
Multivariate Analyses [qnco]    
Sample [sbst]    
included [ftcn]    
LAPTM4B [gngm]    
confirmed [qlco]    
Patients [podg]    
Tumour stage [clna]    
Degree [qlco]    
Differentiation [celf]    
Pathological Staging [inpr]    
PANCREATIC CARCINOMA [neop]    
Primary Surgery [topp]    
Patients [podg]    
LAPTM4B [gngm]    
Levels [qlco]    
Survival [acty]    
Compared [acty]    
Patients [podg]    
LOWER [spco]    
Levels [qlco]    
LAPTM4B [gngm]    
Independent [idcn]    
Prognostic Factor [clna]    
Survival [acty]    
Conclusions [idcn]    
LAPTM4B [gngm]    
Present [qnco]    
Levels [qlco]    
LARGE [qnco]    
Proportion [qnco]    
Patients [podg]    
PANCREATIC CARCINOMA [neop]    
Related [qlco]    
Disease Progression [patf]    
Poor prognosis [fndg]    
LAPTM4B [gngm]    
Represent [acty]    
NEW [qlco]    
Clinical evaluation [hlca]    
treatment [ftcn]    
PANCREATIC CARCINOMA [neop]    
